<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32513711</PMID><DateCompleted><Year>2020</Year><Month>09</Month><Day>01</Day></DateCompleted><DateRevised><Year>2021</Year><Month>09</Month><Day>01</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1091-6490</ISSN><JournalIssue CitedMedium="Internet"><Volume>117</Volume><Issue>26</Issue><PubDate><Year>2020</Year><Month>Jun</Month><Day>30</Day></PubDate></JournalIssue><Title>Proceedings of the National Academy of Sciences of the United States of America</Title><ISOAbbreviation>Proc Natl Acad Sci U S A</ISOAbbreviation></Journal><ArticleTitle>ALS/FTD mutations in UBQLN2 impede autophagy by reducing autophagosome acidification through loss of function.</ArticleTitle><Pagination><StartPage>15230</StartPage><EndPage>15241</EndPage><MedlinePgn>15230-15241</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1073/pnas.1917371117</ELocationID><Abstract><AbstractText>Mutations in <i>UBQLN2</i> cause amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and other neurodegenerations. However, the mechanism by which the UBQLN2 mutations cause disease remains unclear. Alterations in proteins involved in autophagy are prominent in neuronal tissue of human ALS <i>UBQLN2</i> patients and in a transgenic P497S UBQLN2 mouse model of ALS/FTD, suggesting a pathogenic link. Here, we show UBQLN2 functions in autophagy and that ALS/FTD mutant proteins compromise this function. Inactivation of UBQLN2 expression in HeLa cells reduced autophagic flux and autophagosome acidification. The defect in acidification was rescued by reexpression of wild type (WT) UBQLN2 but not by any of the five different UBQLN2 ALS/FTD mutants tested. Proteomic analysis and immunoblot studies revealed P497S mutant mice and UBQLN2 knockout HeLa and NSC34 cells have reduced expression of ATP6v1g1, a critical subunit of the vacuolar ATPase (V-ATPase) pump. Knockout of UBQLN2 expression in HeLa cells decreased turnover of ATP6v1g1, while overexpression of WT UBQLN2 increased biogenesis of ATP6v1g1 compared with P497S mutant UBQLN2 protein. In vitro interaction studies showed that ATP6v1g1 binds more strongly to WT UBQLN2 than to ALS/FTD mutant UBQLN2 proteins. Intriguingly, overexpression of ATP6v1g1 in UBQLN2 knockout HeLa cells increased autophagosome acidification, suggesting a therapeutic approach to overcome the acidification defect. Taken together, our findings suggest that UBQLN2 mutations drive pathogenesis through a dominant-negative loss-of-function mechanism in autophagy and that UBQLN2 functions as an important regulator of the expression and stability of ATP6v1g1. These findings may have important implications for devising therapies to treat <i>UBQLN2</i>-linked ALS/FTD.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Josephine J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Center for Biomedical Engineering and Technology, Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, MD 21201.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Ashley</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Biomedical Engineering and Technology, Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, MD 21201.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greenslade</LastName><ForeName>Jessie E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Center for Biomedical Engineering and Technology, Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, MD 21201.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Higgins</LastName><ForeName>Nicole R</ForeName><Initials>NR</Initials><AffiliationInfo><Affiliation>Center for Biomedical Engineering and Technology, Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, MD 21201.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fan</LastName><ForeName>Cong</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Center for Biomedical Engineering and Technology, Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, MD 21201.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Le</LastName><ForeName>Nhat T T</ForeName><Initials>NTT</Initials><Identifier Source="ORCID">0000-0003-0528-8114</Identifier><AffiliationInfo><Affiliation>Center for Biomedical Engineering and Technology, Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, MD 21201.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tatman</LastName><ForeName>Micaela</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Biomedical Engineering and Technology, Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, MD 21201.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whiteley</LastName><ForeName>Alexandra M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Prado</LastName><ForeName>Miguel A</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0002-4914-1619</Identifier><AffiliationInfo><Affiliation>Department of Cell Biology, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dieriks</LastName><ForeName>Birger V</ForeName><Initials>BV</Initials><Identifier Source="ORCID">0000-0002-9392-3327</Identifier><AffiliationInfo><Affiliation>Department of Anatomy and Medical Imaging, University of Auckland, 1010 Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Brain Research, University of Auckland, 1010 Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Curtis</LastName><ForeName>Maurice A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Department of Anatomy and Medical Imaging, University of Auckland, 1010 Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Brain Research, University of Auckland, 1010 Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>Christopher E</ForeName><Initials>CE</Initials><AffiliationInfo><Affiliation>United Kingdom Dementia Research Institute, King's College London, WC2R 2LS London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Maurice Wohl Clinical Neuroscience Institute, King's College London, SE5 9RT London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Psychiatry, Psychology, and Neuroscience, King's College London, WC2R 2LS London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siddique</LastName><ForeName>Teepu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Ken and Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Faull</LastName><ForeName>Richard L M</ForeName><Initials>RLM</Initials><Identifier Source="ORCID">0000-0003-3385-9498</Identifier><AffiliationInfo><Affiliation>Department of Anatomy and Medical Imaging, University of Auckland, 1010 Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Brain Research, University of Auckland, 1010 Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scotter</LastName><ForeName>Emma L</ForeName><Initials>EL</Initials><Identifier Source="ORCID">0000-0003-4064-3599</Identifier><AffiliationInfo><Affiliation>Centre for Brain Research, University of Auckland, 1010 Auckland, New Zealand.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmacology and Clinical Pharmacology, University of Auckland, 1010 Auckland, New Zealand.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finley</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harvard Medical School, Boston, MA 02115.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Monteiro</LastName><ForeName>Mervyn J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Center for Biomedical Engineering and Technology, Department of Anatomy and Neurobiology, University of Maryland School of Medicine, Baltimore, MD 21201; monteiro@som.umaryland.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS046535</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS078504</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS098243</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS100008</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Proc Natl Acad Sci U S A</MedlineTA><NlmUniqueID>7505876</NlmUniqueID><ISSNLinking>0027-8424</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071183">Autophagy-Related Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C052255">Lamp1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051907">Lysosome-Associated Membrane Glycoproteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C480860">Map1lc3b protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008869">Microtubule-Associated Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071456">Sequestosome-1 Protein</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C101343">Sqstm1 protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C405662">UBQLN2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="C000594810">ATP6V1G1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="D025262">Vacuolar Proton-Translocating ATPases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="ErratumIn"><RefSource>Proc Natl Acad Sci U S A. 2021 Sep 7;118(36):</RefSource><PMID Version="1">34462365</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D048868" MajorTopicYN="N">Adaptor Proteins, Signal Transducing</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071182" MajorTopicYN="N">Autophagosomes</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001343" MajorTopicYN="N">Autophagy</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071183" MajorTopicYN="N">Autophagy-Related Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D003704" MajorTopicYN="N">Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006863" MajorTopicYN="N">Hydrogen-Ion Concentration</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051907" MajorTopicYN="N">Lysosome-Associated Membrane Glycoproteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008869" MajorTopicYN="N">Microtubule-Associated Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000071456" MajorTopicYN="N">Sequestosome-1 Protein</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015854" MajorTopicYN="N">Up-Regulation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D025262" MajorTopicYN="N">Vacuolar Proton-Translocating ATPases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">UBQLN2</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">autophagy</Keyword><Keyword MajorTopicYN="N">ubiquilin</Keyword><Keyword MajorTopicYN="N">vacuolar ATPase pump</Keyword></KeywordList><CoiStatement>The authors declare no competing interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>9</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32513711</ArticleId><ArticleId IdType="pmc">PMC7334651</ArticleId><ArticleId IdType="doi">10.1073/pnas.1917371117</ArticleId><ArticleId IdType="pii">1917371117</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Deng H. X., et al. ., Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature 477, 211&#x2013;215 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3169705</ArticleId><ArticleId IdType="pubmed">21857683</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen H. P., Van Broeckhoven C., van der Zee J., ALS genes in the genomic era and their implications for FTD. Trends Genet. 34, 404&#x2013;423 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29605155</ArticleId></ArticleIdList></Reference><Reference><Citation>Higgins N., Lin B., Monteiro M. J., Lou Gehrig&#x2019;s disease (ALS): UBQLN2 mutations strike out of phase. Structure 27, 879&#x2013;881 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267892</ArticleId><ArticleId IdType="pubmed">31167121</ArticleId></ArticleIdList></Reference><Reference><Citation>Fecto F., Esengul Y. T., Siddique T., Protein recycling pathways in neurodegenerative diseases. Alzheimers Res. Ther. 6, 13 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4055009</ArticleId><ArticleId IdType="pubmed">25031631</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahheydari H., et al. ., Protein quality control and the amyotrophic lateral sclerosis/frontotemporal dementia continuum. Front. Mol. Neurosci. 10, 119 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5423993</ArticleId><ArticleId IdType="pubmed">28539871</ArticleId></ArticleIdList></Reference><Reference><Citation>Edens B. M., et al. ., A novel ALS-associated variant in UBQLN4 regulates motor axon morphogenesis. eLife 6, e25453 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5451210</ArticleId><ArticleId IdType="pubmed">28463112</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu A. L., Wang J., Zheleznyak A., Brown E. J., Ubiquitin-related proteins regulate interaction of vimentin intermediate filaments with the plasma membrane. Mol. Cell 4, 619&#x2013;625 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10549293</ArticleId></ArticleIdList></Reference><Reference><Citation>Mah A. L., Perry G., Smith M. A., Monteiro M. J., Identification of ubiquilin, a novel presenilin interactor that increases presenilin protein accumulation. J. Cell Biol. 151, 847&#x2013;862 (2000).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2169435</ArticleId><ArticleId IdType="pubmed">11076969</ArticleId></ArticleIdList></Reference><Reference><Citation>Conklin D., Holderman S., Whitmore T. E., Maurer M., Feldhaus A. L., Molecular cloning, chromosome mapping and characterization of UBQLN3 a testis-specific gene that contains an ubiquitin-like domain. Gene 249, 91&#x2013;98 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10831842</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleijnen M. F., et al. ., The hPLIC proteins may provide a link between the ubiquitination machinery and the proteasome. Mol. Cell 6, 409&#x2013;419 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10983987</ArticleId></ArticleIdList></Reference><Reference><Citation>Safren N., Chang L., Dziki K. M., Monteiro M. J., Signature changes in ubiquilin expression in the R6/2 mouse model of Huntington&#x2019;s disease. Brain Res. 1597, 37&#x2013;46 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4340744</ArticleId><ArticleId IdType="pubmed">25511991</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaye F. J., et al. ., A family of ubiquitin-like proteins binds the ATPase domain of Hsp70-like Stch. FEBS Lett. 467, 348&#x2013;355 (2000).</Citation><ArticleIdList><ArticleId IdType="pubmed">10675567</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjerpe R., et al. ., UBQLN2 mediates autophagy-independent protein aggregate clearance by the proteasome. Cell 166, 935&#x2013;949 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5003816</ArticleId><ArticleId IdType="pubmed">27477512</ArticleId></ArticleIdList></Reference><Reference><Citation>Ko H. S., Uehara T., Tsuruma K., Nomura Y., Ubiquilin interacts with ubiquitylated proteins and proteasome through its ubiquitin-associated and ubiquitin-like domains. FEBS Lett. 566, 110&#x2013;114 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15147878</ArticleId></ArticleIdList></Reference><Reference><Citation>Massey L. K., et al. ., Overexpression of ubiquilin decreases ubiquitination and degradation of presenilin proteins. J. Alzheimers Dis. 6, 79&#x2013;92 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15004330</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L., Monteiro M. J., Defective proteasome delivery of polyubiquitinated proteins by ubiquilin-2 proteins containing ALS mutations. PLoS One 10, e0130162 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4468220</ArticleId><ArticleId IdType="pubmed">26075709</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., et al. ., Structure of hRpn10 bound to UBQLN2 UBL illustrates basis for complementarity between shuttle factors and substrates at the proteasome. J. Mol. Biol. 431, 939&#x2013;955 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6389388</ArticleId><ArticleId IdType="pubmed">30664872</ArticleId></ArticleIdList></Reference><Reference><Citation>Harman C. A., Monteiro M. J., The specificity of ubiquitin binding to ubiquilin-1 is regulated by sequences besides its UBA domain. Biochim. Biophys. Acta, Gen. Subj. 1863, 1568&#x2013;1574 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6679980</ArticleId><ArticleId IdType="pubmed">31175912</ArticleId></ArticleIdList></Reference><Reference><Citation>Stieren E. S., et al. ., Ubiquilin-1 is a molecular chaperone for the amyloid precursor protein. J. Biol. Chem. 286, 35689&#x2013;35698 (2011).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3195644</ArticleId><ArticleId IdType="pubmed">21852239</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#x2019;Diaye E. N., et al. ., The ubiquitin-like protein PLIC-2 is a negative regulator of G protein-coupled receptor endocytosis. Mol. Biol. Cell 19, 1252&#x2013;1260 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2262968</ArticleId><ArticleId IdType="pubmed">18199683</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothenberg C., et al. ., Ubiquilin functions in autophagy and is degraded by chaperone-mediated autophagy. Hum. Mol. Genet. 19, 3219&#x2013;3232 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2908472</ArticleId><ArticleId IdType="pubmed">20529957</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee D. Y., Arnott D., Brown E. J., Ubiquilin4 is an adaptor protein that recruits Ubiquilin1 to the autophagy machinery. EMBO Rep. 14, 373&#x2013;381 (2013).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3615663</ArticleId><ArticleId IdType="pubmed">23459205</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x15e;ent&#xfc;rk M., et al. ., Ubiquilins regulate autophagic flux through mTOR signalling and lysosomal acidification. Nat. Cell Biol. 21, 384&#x2013;396 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6534127</ArticleId><ArticleId IdType="pubmed">30804504</ArticleId></ArticleIdList></Reference><Reference><Citation>N&#x2019;Diaye E. N., et al. ., PLIC proteins or ubiquilins regulate autophagy-dependent cell survival during nutrient starvation. EMBO Rep. 10, 173&#x2013;179 (2009).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2637314</ArticleId><ArticleId IdType="pubmed">19148225</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J., et al. ., Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion. Acta Neuropathol. 123, 825&#x2013;839 (2012).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3521561</ArticleId><ArticleId IdType="pubmed">22426854</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotter E. L., et al. ., C9ORF72 and UBQLN2 mutations are causes of amyotrophic lateral sclerosis in New Zealand: A genetic and pathologic study using banked human brain tissue. Neurobiol. Aging 49, 214.e1&#x2013;214.e5 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27480424</ArticleId></ArticleIdList></Reference><Reference><Citation>Gkazi S. A., et al. ., Striking phenotypic variation in a family with the P497H UBQLN2 mutation including amyotrophic lateral sclerosis, spastic paraplegia, and frontotemporal dementia. Neurobiol. Aging 73, 229.e5&#x2013;229.e9 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30348461</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams K. L., et al. ., UBQLN2/ubiquilin 2 mutation and pathology in familial amyotrophic lateral sclerosis. Neurobiol. Aging 33, 2527.e3&#x2013;2527.e10 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22717235</ArticleId></ArticleIdList></Reference><Reference><Citation>Labbadia J., Morimoto R. I., The biology of proteostasis in aging and disease. Annu. Rev. Biochem. 84, 435&#x2013;464 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4539002</ArticleId><ArticleId IdType="pubmed">25784053</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma S., Attarwala I. Y., Xie X. Q., SQSTM1/p62: A potential target for neurodegenerative disease. ACS Chem. Neurosci. 10, 2094&#x2013;2114 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6712989</ArticleId><ArticleId IdType="pubmed">30657305</ArticleId></ArticleIdList></Reference><Reference><Citation>Pankiv S., et al. ., p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J. Biol. Chem. 282, 24131&#x2013;24145 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17580304</ArticleId></ArticleIdList></Reference><Reference><Citation>Glick D., Barth S., Macleod K. F., Autophagy: Cellular and molecular mechanisms. J. Pathol. 221, 3&#x2013;12 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2990190</ArticleId><ArticleId IdType="pubmed">20225336</ArticleId></ArticleIdList></Reference><Reference><Citation>Dikic I., Elazar Z., Mechanism and medical implications of mammalian autophagy. Nat. Rev. Mol. Cell Biol. 19, 349&#x2013;364 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29618831</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizushima N., Methods for monitoring autophagy. Int. J. Biochem. Cell Biol. 36, 2491&#x2013;2502 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15325587</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorrie G. H., et al. ., Dendritic spinopathy in transgenic mice expressing ALS/dementia-linked mutant UBQLN2. Proc. Natl. Acad. Sci. U.S.A. 111, 14524&#x2013;14529 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4209984</ArticleId><ArticleId IdType="pubmed">25246588</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia Y., et al. ., Pathogenic mutation of UBQLN2 impairs its interaction with UBXD8 and disrupts endoplasmic reticulum-associated protein degradation. J. Neurochem. 129, 99&#x2013;106 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24215460</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q., et al. ., Pathogenic Ubqln2 gains toxic properties to induce neuron death. Acta Neuropathol. 129, 417&#x2013;428 (2015).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4777328</ArticleId><ArticleId IdType="pubmed">25388785</ArticleId></ArticleIdList></Reference><Reference><Citation>Le N. T., et al. ., Motor neuron disease, TDP-43 pathology, and memory deficits in mice expressing ALS-FTD-linked UBQLN2 mutations. Proc. Natl. Acad. Sci. U.S.A. 113, E7580&#x2013;E7589 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5127348</ArticleId><ArticleId IdType="pubmed">27834214</ArticleId></ArticleIdList></Reference><Reference><Citation>Komatsu M., et al. ., Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 131, 1149&#x2013;1163 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">18083104</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizushima N., Komatsu M., Autophagy: Renovation of cells and tissues. Cell 147, 728&#x2013;741 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">22078875</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshimori T., Yamamoto A., Moriyama Y., Futai M., Tashiro Y., Bafilomycin A1, a specific inhibitor of vacuolar-type H(+)-ATPase, inhibits acidification and protein degradation in lysosomes of cultured cells. J. Biol. Chem. 266, 17707&#x2013;17712 (1991).</Citation><ArticleIdList><ArticleId IdType="pubmed">1832676</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoshii S. R., Mizushima N., Monitoring and measuring autophagy. Int. J. Mol. Sci. 18, e1865 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5618514</ArticleId><ArticleId IdType="pubmed">28846632</ArticleId></ArticleIdList></Reference><Reference><Citation>Kodama Y., Hu C. D., An improved bimolecular fluorescence complementation assay with a high signal-to-noise ratio. Biotechniques 49, 793&#x2013;805 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">21091444</ArticleId></ArticleIdList></Reference><Reference><Citation>Kodama Y., Hu C. D., Bimolecular fluorescence complementation (BiFC): A 5-year update and future perspectives. Biotechniques 53, 285&#x2013;298 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">23148879</ArticleId></ArticleIdList></Reference><Reference><Citation>Dao T. P., et al. ., Ubiquitin modulates liquid-liquid phase separation of UBQLN2 via disruption of multivalent interactions. Mol. Cell 69, 965&#x2013;978.e6 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6181577</ArticleId><ArticleId IdType="pubmed">29526694</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander E. J., et al. ., Ubiquilin 2 modulates ALS/FTD-linked FUS-RNA complex dynamics and stress granule formation. Proc. Natl. Acad. Sci. U.S.A. 115, E11485&#x2013;E11494 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6298105</ArticleId><ArticleId IdType="pubmed">30442662</ArticleId></ArticleIdList></Reference><Reference><Citation>Ugolino J., et al. ., Overexpression of human Atp13a2Isoform-1 protein protects cells against manganese and starvation-induced toxicity. PLoS One 14, e0220849 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6687281</ArticleId><ArticleId IdType="pubmed">31393918</ArticleId></ArticleIdList></Reference><Reference><Citation>Polson H. E., et al. ., Mammalian Atg18 (WIPI2) localizes to omegasome-anchored phagophores and positively regulates LC3 lipidation. Autophagy 6, 506&#x2013;522 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20505359</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf6;tzl J. K., et al. ., Common pathobiochemical hallmarks of progranulin-associated frontotemporal lobar degeneration and neuronal ceroid lipofuscinosis. Acta Neuropathol. 127, 845&#x2013;860 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24619111</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilpin K. M., Chang L., Monteiro M. J., ALS-linked mutations in ubiquilin-2 or hnRNPA1 reduce interaction between ubiquilin-2 and hnRNPA1. Hum. Mol. Genet. 24, 2565&#x2013;2577 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25616961</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharkey L. M., et al. ., Mutant UBQLN2 promotes toxicity by modulating intrinsic self-assembly. Proc. Natl. Acad. Sci. U.S.A. 115, E10495&#x2013;E10504 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6217421</ArticleId><ArticleId IdType="pubmed">30333186</ArticleId></ArticleIdList></Reference><Reference><Citation>Maxson M. E., Grinstein S., The vacuolar-type H+-ATPase at a glance&#x2014;More than a proton pump. J. Cell Sci. 127, 4987&#x2013;4993 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">25453113</ArticleId></ArticleIdList></Reference><Reference><Citation>Lie P. P. Y., Nixon R. A., Lysosome trafficking and signaling in health and neurodegenerative diseases. Neurobiol. Dis. 122, 94&#x2013;105 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6381838</ArticleId><ArticleId IdType="pubmed">29859318</ArticleId></ArticleIdList></Reference><Reference><Citation>De Luca M., et al. ., RILP regulates vacuolar ATPase through interaction with the V1G1 subunit. J. Cell Sci. 127, 2697&#x2013;2708 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24762812</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomashek J. J., Graham L. A., Hutchins M. U., Stevens T. H., Klionsky D. J., V1-situated stalk subunits of the yeast vacuolar proton-translocating ATPase. J. Biol. Chem. 272, 26787&#x2013;26793 (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">9334266</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohira M., et al. ., The E and G subunits of the yeast V-ATPase interact tightly and are both present at more than one copy per V1 complex. J. Biol. Chem. 281, 22752&#x2013;22760 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">16774922</ArticleId></ArticleIdList></Reference><Reference><Citation>Breton S., Brown D., New insights into the regulation of V-ATPase-dependent proton secretion. Am. J. Physiol. Renal Physiol. 292, F1&#x2013;F10 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17032935</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshansky V., Rubinstein J. L., Gr&#xfc;ber G., Eukaryotic V-ATPase: Novel structural findings and functional insights. Biochim. Biophys. Acta 1837, 857&#x2013;879 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24508215</ArticleId></ArticleIdList></Reference><Reference><Citation>Sautin Y. Y., Lu M., Gaugler A., Zhang L., Gluck S. L., Phosphatidylinositol 3-kinase-mediated effects of glucose on vacuolar H+-ATPase assembly, translocation, and acidification of intracellular compartments in renal epithelial cells. Mol. Cell. Biol. 25, 575&#x2013;589 (2005).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC543406</ArticleId><ArticleId IdType="pubmed">15632060</ArticleId></ArticleIdList></Reference><Reference><Citation>Itakura E., et al. ., Ubiquilins chaperone and triage mitochondrial membrane proteins for degradation. Mol. Cell 63, 21&#x2013;33 (2016).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4942676</ArticleId><ArticleId IdType="pubmed">27345149</ArticleId></ArticleIdList></Reference><Reference><Citation>Whiteley A. M., et al. ., Ubiquilin1 promotes antigen-receptor mediated proliferation by eliminating mislocalized mitochondrial proteins. eLife 6, e26435 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5608509</ArticleId><ArticleId IdType="pubmed">28933694</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurlawala Z., Shah P. P., Shah C., Beverly L. J., The STI and UBA domains of UBQLN1 are critical determinants of substrate interaction and proteostasis. J. Cell. Biochem. 118, 2261&#x2013;2270 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5462870</ArticleId><ArticleId IdType="pubmed">28075048</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsuda M., Koide T., Yorihuzi T., Hosokawa N., Nagata K., Molecular cloning of a novel ubiquitin-like protein, UBIN, that binds to ER targeting signal sequences. Biochem. Biophys. Res. Commun. 280, 535&#x2013;540 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11162551</ArticleId></ArticleIdList></Reference><Reference><Citation>Gavriilidis C., et al. ., The MTM1-UBQLN2-HSP complex mediates degradation of misfolded intermediate filaments in skeletal muscle. Nat. Cell Biol. 20, 198&#x2013;210 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29358706</ArticleId></ArticleIdList></Reference><Reference><Citation>Ford D. L., Monteiro M. J., Dimerization of ubiquilin is dependent upon the central region of the protein: Evidence that the monomer, but not the dimer, is involved in binding presenilins. Biochem. J. 399, 397&#x2013;404 (2006).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1615901</ArticleId><ArticleId IdType="pubmed">16813565</ArticleId></ArticleIdList></Reference><Reference><Citation>Dao T. P., et al. ., ALS-linked mutations affect UBQLN2 oligomerization and phase separation in a position- and amino acid-dependent manner. Structure 27, 937&#x2013;951.e5 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6551275</ArticleId><ArticleId IdType="pubmed">30982635</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramesh N., Pandey U. B., Autophagy dysregulation in ALS: When protein aggregates get out of hand. Front. Mol. Neurosci. 10, 263 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5572252</ArticleId><ArticleId IdType="pubmed">28878620</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudnick N. D., et al. ., Distinct roles for motor neuron autophagy early and late in the SOD1G93A mouse model of ALS. Proc. Natl. Acad. Sci. U.S.A. 114, E8294&#x2013;E8303 (2017).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5625902</ArticleId><ArticleId IdType="pubmed">28904095</ArticleId></ArticleIdList></Reference><Reference><Citation>Ling S. C., et al. ., Overriding FUS autoregulation in mice triggers gain-of-toxic dysfunctions in RNA metabolism and autophagy-lysosome axis. eLife 8, e40811 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6389288</ArticleId><ArticleId IdType="pubmed">30747709</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J. H., et al. ., Lysosomal proteolysis and autophagy require presenilin 1 and are disrupted by Alzheimer-related PS1 mutations. Cell 141, 1146&#x2013;1158 (2010).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3647462</ArticleId><ArticleId IdType="pubmed">20541250</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y., et al. ., Lysosomal dysfunction in down syndrome is APP-dependent and mediated by APP-&#x3b2;CTF (C99). J. Neurosci. 39, 5255&#x2013;5268 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6607756</ArticleId><ArticleId IdType="pubmed">31043483</ArticleId></ArticleIdList></Reference><Reference><Citation>National Research Council , Guide for the Care and Use of Laboratory Animals (National Academies Press, Washington, DC, ed. 8, 2011).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>